1. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report. 2001, 13:3–31.
2. Centers for Disease Control and Prevention: Recommendations of the US Public Health Task Force on the use of zidovudine to reduce perinatal transmission of human immunodefiency virus. MMWR Morb Mortal Wkly Rep 1994, 43:1–20.
3. Abrams EJ, Weedon J, Bertolli J, et al.: Aging cohort of perinatally human immunodefiency virus-infected children in New York City. Pediatr Infect Dis J 2001, 20:511–517.
4. The European Mode of Delivery Collaboration: Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-l transmission: a randomized clinical trial. Lancet 1999, 353:1035–1039.
5. Stek A, Kramer F, Fassett M, et al.: The safety and efficacy of protease inhibitor therapy for HIV infection during pregnancy [abstract]. Am J Obstet Gynecol 1999, 180(suppl):7.